Citations 0
Editor's Correspondence
July 25, 2005

Vasopressin Has Cost and Administration Advantages Over Epinephrine in Cardiac Arrest

Author Affiliations

Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2005

Arch Intern Med. 2005;165(14):1663. doi:10.1001/archinte.165.14.1663-a

As a Course Director for Advance Cardiac Life Support (ACLS) classes, I read with interest the meta-analysis by Aung and Htay1(p23) regarding vasopressin in the treatment of cardiac arrest. They conclude that although vasopressin “may be at least equivalent to epinephrine,”1(p23) guidelines “should not recommend vasopressin in resuscitation protocols.”1(p17) Their primary objection to the use of vasopressin appears to be one of cost.

First Page Preview View Large
First page PDF preview
First page PDF preview